CN105131974B - Phenanthridone-structure heterocyclic polymerizable liquid crystal compound and preparation method thereof - Google Patents

Phenanthridone-structure heterocyclic polymerizable liquid crystal compound and preparation method thereof Download PDF

Info

Publication number
CN105131974B
CN105131974B CN201510451695.XA CN201510451695A CN105131974B CN 105131974 B CN105131974 B CN 105131974B CN 201510451695 A CN201510451695 A CN 201510451695A CN 105131974 B CN105131974 B CN 105131974B
Authority
CN
China
Prior art keywords
liquid crystal
compound
polymerizable liquid
crystal compound
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510451695.XA
Other languages
Chinese (zh)
Other versions
CN105131974A (en
Inventor
黄达
谭玉东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Hecheng Advanced Materials Co ltd
Original Assignee
Jiangsu Hecheng Advanced Materials Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hecheng Advanced Materials Co ltd filed Critical Jiangsu Hecheng Advanced Materials Co ltd
Priority to CN201510451695.XA priority Critical patent/CN105131974B/en
Publication of CN105131974A publication Critical patent/CN105131974A/en
Application granted granted Critical
Publication of CN105131974B publication Critical patent/CN105131974B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

The invention provides a phenanthridone-structure heterocyclic polymerizable liquid crystal compound shown in a general formula I. The phenanthridone compound has a high refractive index, can be cured under the action of heating or ultraviolet and visible light, does not yellow easily, has good film forming ability after curing, can be widely used in the fields of panel display, flexible display and other optical films.

Description

Heterocyclic polymerizable liquid crystal compound with phenanthridinone structure and preparation method thereof
Technical Field
The invention relates to a polymerizable liquid crystal compound, a preparation method of the polymerizable liquid crystal compound and application of the polymerizable liquid crystal compound in an optical film.
Background
The polymerizable liquid crystal compound plays a positive role in the fields of specific optical films such as a naked-eye 3D Lenticular Lens film (lenticulars), an optical retardation film (Retard), a patterned retardation film (Pattern Retard) and the like because of its unique liquid fluidity and crystal order.
The retardation film can realize conversion among various polarization states, rotation of a polarization plane and modulation of various polarized lights, and has wide application in the fields of optical fiber communication, photoelastic, optical precision measurement, optical compensation of flat panel display and the like. In particular, the liquid crystal display device plays an increasingly important role in optical compensation of liquid crystal display. For example, for a passive matrix vertical alignment liquid crystal display, under the conditions of no electric field and oblique incidence of light, a certain phase delay is generated due to the existence of an included angle when incident light passes through a liquid crystal layer, at the moment, the phase delay caused by the oblique incidence can be effectively compensated by adopting a delay film, and oblique-view-angle light leakage is restrained, so that the visual angle characteristic of the liquid crystal display is improved. In addition, for color liquid crystal display, display is realized by modulating RGB three primary colors, not only the retardation is precisely controlled, but also the dispersion performance of the retardation film is strictly required, and the dispersion performance of the retardation film has a significant influence on color liquid crystal display.
As for the non-polymerizable liquid crystal with high refractive index, there have been many scientific researches, such as reviewed by Zhang Chiyong et al (research progress of high birefringent liquid crystal compound, liquid crystal and display, 2014,29, 873-. The central group is mainly composed of cyclic structures, such as benzene ring, naphthalene ring or cyclohexane, bridging groups can be introduced among the cyclic structures, and side groups can be introduced on the rings.
Wherein SL and SR are left and right groups, RL and RR are left and right cyclic groups, and M is a bridging group.
The who et al (molecular design and simulation calculation of fast high birefringence nematic liquid crystal, liquid crystal and display, 2009,24,15-21) provides a whole set of semi-empirical quantum chemical algorithms, and can obtain Δ n of liquid crystal material through simulation calculation.
In the non-liquid crystal domain, the high refractive index resin is usually added with inorganic compound and fluorine-containing group or sulfur-containing atom to improve the refractive index. However, inorganic compounds have adverse effects on liquid crystals in liquid crystals, and have a large odor during synthesis of sulfur atoms, which is not favorable for industrial production.
The refractive index of the conventional polymerizable liquid crystal is about 0.15. The existing high-refractive-index polymerizable liquid crystal contains acetylene bonds and cyano groups, and is easy to cause yellowing and high in viscosity. Therefore, there is a particular need for new polymerizable liquid crystals free of acetylenic and cyano groups that meet the needs of optical films.
Disclosure of Invention
The purpose of the invention is as follows: the invention aims to overcome the defects of the prior art and provide a heterocyclic ring-containing high-refractive-index polymerizable liquid crystal compound. Another object of the present invention is to provide a method for preparing a heterocyclic ring-containing polymerizable liquid crystal compound. It is still another object of the present invention to provide a use of the heterocyclic ring-containing polymerizable liquid crystal compound.
The technical scheme is as follows: in order to achieve the above object, the present invention provides a heterocyclic polymerizable liquid crystal compound having a phenanthridinone structure of the general formula i:
wherein,
R1is hydrogen or alkyl with 1-6 carbon atoms, or aromatic hydrocarbon which can be mono-or polysubstituted by methyl;
R2is hydrogen or methyl;
x is a single bond or carbonyl;
z is-COO-or-OCO-;
m is 0 or 1;
n is an integer of 1 to 11.
In some embodiments of the invention, the compound of formula I is selected from the group consisting of compounds of formula I-1:
wherein,
R1is hydrogen or alkyl with 1-6 carbon atoms;
R2is hydrogen or methyl;
x is a single bond or carbonyl;
m is 0 or 1;
n is an integer of 1 to 11.
In some embodiments of the invention, the compound of formula I is selected from the group consisting of compounds of formula I-2:
wherein,
R2is hydrogen or methyl;
n is an integer of 1 to 11.
In some preferred embodiments of the present invention, the compound of formula I-1 is selected from the group consisting of compounds of formulae I-1-1 to I-1-6:
and
in some preferred embodiments of the present invention, the compound of formula I-2 is selected from the group consisting of compounds of formulae I-2-1 to I-2-4:
and
the synthetic route of the general formula I-1 is shown as follows:
wherein R is1Is hydrogen or alkyl with 1-6 carbon atoms; r2Is hydrogen or methyl; x is a single bond or carbonyl; m is 0 or 1; n is an integer of 1 to 11.
Adding A and B in a certain molar ratio into a reaction vessel, simultaneously adding a corresponding polymerization inhibitor (such as hydroquinone), a catalyst (such as p-toluenesulfonic acid) and a solvent (such as benzene and substituted benzene solvents), performing reflux reaction to obtain a crude product I-1, and purifying by passing through a column to obtain a refined product I-1.
The synthetic route of the general formula I-2 is shown as follows:
wherein R is2Is hydrogen or methyl; n is an integer of 1 to 11.
Adding C and D in a certain molar ratio into a reaction container, simultaneously adding a corresponding polymerization inhibitor (such as hydroquinone), a catalyst (such as p-toluenesulfonic acid) and a solvent (such as benzene and substituted benzene solvents), performing reflux reaction to obtain a crude product I-2, and purifying by passing through a column to obtain a refined product I-2.
The invention also provides application of the compound with the general formula I in the fields of flat panel display, flexible display and functional optical films.
Detailed Description
The invention will be illustrated below with reference to specific embodiments. It should be noted that the following examples are illustrative of the present invention, and are not intended to limit the present invention.
The mother liquid crystal is selected from commercial liquid crystal with the serial number of TS023-102 produced by Jiangsu Hecheng display science and technology GmbH. The obtained compound was dissolved in a mother substance in a weight ratio of 20%, and n was adjusted by Abbe refractometeroAnd neThe measurements were made and △ n was calculated and the birefringence △ n (25 ℃, 589nm) of the polymerized liquid crystal composition was extrapolated in a linear relationship based on the ratio of the composition in the matrixoAnd neThe angle of the ocular needs to be adjusted, the difference between the two is 90 degrees, and △ n is equal to ne-no
Example 1
1.1mmol of Compound A1 and 1mmol of Compound B1 were put in a 50mL round bottom flask, and 0.1mmol of hydroquinone, 1mmol of p-toluenesulfonic acid and 20mL of a toluene solution were added, followed by reflux reaction at 115 ℃ for 4 hours. The product was extracted with ethyl acetate and passed through a column to give 0.22 g of a pale yellow compound I-1-1.
1H NMR(CHCl3):8.58(1H),8.50(1H),8.31(1H),8.15(1H),8.09(2H),7.80(1H),7.68(1H),7.56(1H),7.47(2H),6.36(1H),6.12(1H),5.97(1H),4.26(2H),4.09(2H),3.89(3H),1.80(2H),1.65(2H).
Compound I-1-1 was found to have Δ n ═ 0.25.
Example 2
1.1mmol of Compound A1 and 1mmol of Compound B2 were put in a 50mL round bottom flask, and 0.1mmol of hydroquinone, 1mmol of p-toluenesulfonic acid and 20mL of a toluene solution were added, followed by reflux reaction at 115 ℃ for 4 hours. The product was extracted with ethyl acetate and passed through a column to give 0.31 g of a pale yellow compound I-1-5.
1H NMR(CHCl3):8.58(1H),8.49(1H),8.39(1H),8.15(1H),7.90(2H),7.79(1H),7.68(1H),7.55(1H),7.47(2H),6.38(1H),6.30(1H),4.17(2H),4.09(2H),3.89(3H),2.01(3H),1.77(2H),1.67(2H),1.48(2H),1.38(2H)。
Compound I-1-5 was found to have Δ n of 0.26.
Example 3
1.1mmol of Compound A2 and 1mmol of Compound B3 were put in a 50mL round bottom flask, and 0.1mmol of hydroquinone, 1mmol of p-toluenesulfonic acid and 20mL of a toluene solution were added, followed by reflux reaction at 115 ℃ for 4 hours. The product was extracted with ethyl acetate and passed through a column to give 0.32 g of a pale yellow compound I-1-6.
1H NMR(CHCl3):8.52(2H),8.28(1H),8.10(1H),7.93(2H),7.81(1H),7.71(1H),7.52(1H),7.45(2H),6.33(1H),6.05(2H),4.74(1H),4.23(2H),4.09(1H),3.92(2H),1.65(4H),1.46(4H),1.22(3H)。
Compound I-1-6 was found to have Δ n of 0.25.
Example 4
1mmol of Compound A3 and 1.1mmol of Compound B4 were put in a 50mL round bottom flask, and 0.1mmol of hydroquinone, 1mmol of p-toluenesulfonic acid and 20mL of a toluene solution were added, followed by reflux reaction at 115 ℃ for 4 hours. The product was extracted with ethyl acetate and passed through a column to give 0.29 g of a pale yellow compound I-2-1.
1H NMR(CHCl3):8.49(1H),8.25(1H),8.00(3H)7.68(1H),7.51(1H),7.27(1H),7.14(2H),7.09(1H),7.04(3H),6.36(1H),6.00(2H),4.10(4H),2.22(6H),1.92(2H),1.70(2H)。
Compound I-2-1 was found to have Δ n ═ 0.25.
Example 5
The polymerizable liquid crystal compounds I-1-1, I-1-5, I-1-6 and I-2-1 obtained in examples 1 to 4 were cured to obtain optical films which were not yellowed by sunlight irradiation for 10 days. The cured film has no pinhole defect and color stripe and has good film forming property.
The experiment results show that the heterocyclic polymerizable liquid crystal compound containing the phenanthridinone structure has high birefringence, and delta n is larger than 0.25. And the experimental result shows that the polymerizable liquid crystal compound provided by the invention is not easy to turn yellow, has long service life, can be used for preparing a film without pinhole defects and colored stripes, has good film forming property, can meet various requirements of optical films, and has a very good technical effect compared with the prior art.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.

Claims (8)

1. A heterocyclic polymerizable liquid crystal compound having a phenanthridinone structure of formula I:
wherein,
R1is hydrogen or alkyl with 1-6 carbon atoms or phenyl substituted by methyl;
R2is hydrogen or methyl;
x is a single bond or carbonyl;
z is-COO-or-OCO-;
m is 0 or 1;
n is an integer of 1 to 11.
2. The heterocyclic polymerizable liquid crystal compound according to claim 1, wherein the compound is selected from the group consisting of compounds represented by general formula i-1:
wherein,
R1is hydrogen or alkyl with 1-6 carbon atoms;
R2is hydrogen or methyl;
x is a single bond or carbonyl;
m is 0 or 1;
n is an integer of 1 to 11.
3. The heterocyclic polymerizable liquid crystal compound according to claim 1, wherein the compound is selected from the group consisting of compounds represented by general formula i-2:
wherein,
R2is hydrogen or methyl;
n is an integer of 1 to 11.
4. The heterocyclic polymerizable liquid crystal compound according to claim 2, wherein the compound of the general formula i-1 is selected from the group consisting of compounds represented by general formulae i-1-1 to i-1-6:
5. the heterocyclic polymerizable liquid crystal compound according to claim 3, wherein the compound of the formula i-2 is selected from the group consisting of compounds represented by the formulae i-2-1 to i-2-4:
6. a method for preparing a heterocyclic polymerizable liquid crystal compound represented by the general formula I-1, which is characterized by comprising the following steps:
adding a compound A and a compound B in a certain molar ratio into a reaction vessel, simultaneously adding a corresponding polymerization inhibitor, a catalyst and a solvent, performing reflux reaction, and purifying by a column to obtain a refined compound of a general formula I-1:
wherein R is1Is hydrogen or alkyl with 1-6 carbon atoms; r2Is hydrogen or methyl; x is a single bond or carbonyl; m is 0 or 1; n is an integer of 1 to 11.
7. The preparation method of the heterocyclic polymerizable liquid crystal compound shown as the general formula I-2 is characterized by comprising the following steps:
adding compounds C and D in a certain molar ratio into a reaction vessel, simultaneously adding a corresponding polymerization inhibitor, a catalyst and a solvent, performing reflux reaction, and performing column purification to obtain a refined compound of a general formula I-2:
wherein R is2Is hydrogen or methyl; n is an integer of 1 to 11.
8. Use of the heterocyclic polymerizable liquid crystal compound according to any one of claims 1 to 5 for the production of flat panel displays, flexible displays and other optical films.
CN201510451695.XA 2015-07-28 2015-07-28 Phenanthridone-structure heterocyclic polymerizable liquid crystal compound and preparation method thereof Active CN105131974B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510451695.XA CN105131974B (en) 2015-07-28 2015-07-28 Phenanthridone-structure heterocyclic polymerizable liquid crystal compound and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510451695.XA CN105131974B (en) 2015-07-28 2015-07-28 Phenanthridone-structure heterocyclic polymerizable liquid crystal compound and preparation method thereof

Publications (2)

Publication Number Publication Date
CN105131974A CN105131974A (en) 2015-12-09
CN105131974B true CN105131974B (en) 2017-04-12

Family

ID=54717559

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510451695.XA Active CN105131974B (en) 2015-07-28 2015-07-28 Phenanthridone-structure heterocyclic polymerizable liquid crystal compound and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105131974B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107082761B (en) * 2017-04-17 2020-04-03 上海大学 Phenanthridinone or benzophenanthridinone derivative and synthesis method thereof
JP7491660B2 (en) * 2017-08-21 2024-05-28 住友化学株式会社 Retardation plate with optical compensation function
KR102195455B1 (en) * 2018-05-03 2020-12-28 주식회사 엘지화학 Polymerizable liquid crystal compound, liquid crystal composition for optical element, polymer, optically anisotropic body, and optical element for display device
JP7279385B2 (en) * 2019-02-07 2023-05-23 東ソー株式会社 Polymerizable compounds, polymers and retardation films

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0946513B1 (en) * 1996-12-19 2002-01-30 Aventis Research & Technologies GmbH & Co. KG Derivatives of 6-fluorophenanthridine for liquid crystal mixtures
CN102977017A (en) * 2012-12-24 2013-03-20 湖南大学 Method for catalytically preparing 6(5H)-phenanthridine ketone by copper component
CN103275003A (en) * 2013-05-22 2013-09-04 浙江大学 Method for preparing phenanthridinone derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723733B2 (en) * 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
US6630254B2 (en) * 2001-04-10 2003-10-07 National Research Council Of Canada Conjugated polycarbazole derivatives in Organic Light Emitting Diodes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0946513B1 (en) * 1996-12-19 2002-01-30 Aventis Research & Technologies GmbH & Co. KG Derivatives of 6-fluorophenanthridine for liquid crystal mixtures
CN102977017A (en) * 2012-12-24 2013-03-20 湖南大学 Method for catalytically preparing 6(5H)-phenanthridine ketone by copper component
CN103275003A (en) * 2013-05-22 2013-09-04 浙江大学 Method for preparing phenanthridinone derivative

Also Published As

Publication number Publication date
CN105131974A (en) 2015-12-09

Similar Documents

Publication Publication Date Title
CN105131974B (en) Phenanthridone-structure heterocyclic polymerizable liquid crystal compound and preparation method thereof
JP7205980B2 (en) laminated film
CN101870651B (en) Compound, composition containing same, membrane, color filter and flat display device
CN102939327B (en) Optical film and display device using the same
KR102477376B1 (en) Composition, optical film, and methods of producing the composition and the optical film
TWI611213B (en) Stereoscopic display system, glasses for stereoscopic display system, and display device for stereoscopic display system
JP2012021068A (en) Composition and optical film
CN103732638B (en) Multipolymer and comprise the liquid crystal aligning layer of cured article of this multipolymer
JP5443720B2 (en) Composition, optical film and method for producing the same, optical member, and display device
CN105061213B (en) Polymerizable compound with four-atomic-bridge keys and preparation method and application of polymerizable compound
JP2013071956A (en) Composition and optical film
CN103619803B (en) Cinnamic acid derivative and polymkeric substance thereof and the liquid crystal aligning layer be made up of its cured article
WO2011122598A1 (en) Polymer for use in a liquid-crystal alignment layer
CN105518035A (en) Compound, polymer, liquid crystal alignment film, liquid crystal display element, and optical anisotropic body
TW201835313A (en) Liquid crystal element, method for manufacturing same, and display device
KR101495129B1 (en) Method for producing composition
JP5566701B2 (en) Retardation film
KR102566075B1 (en) Compound, liquid crystal composition, optical film, polarizing plate, and optical display
KR20150139430A (en) The novel bimesogenic compound
JP2021532412A (en) Polarizer
TW200918933A (en) Optical film and method for making an optical film
JP2011227483A (en) Composition for vertical orientation layer
TWI567171B (en) Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optically anisotropic body comprising the composition
TW201412795A (en) Polymerizable liquid crystal compound, liquid crystal composition comprising the compound, and optically anisotropic body
KR20140130419A (en) Method for producing compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant